Kura Oncology (NASDAQ:KURA) fell ~9% in regular trading on Thursday even as the cancer drug developer and its partner Kyowa Kirin (OTCPK:KYKOF) announced a mid-stage trial win for their jointly ...

Kura plans to submit an NDA for ziftomenib in Q2 2025 and initiate two Phase 3 trials in newly diagnosed AML patients in H2 2025. Get two weeks of free access to pro-level trading tools ...

TD Cowen analyst Phil Nadeau maintained a Buy rating on Kura Oncology (KURA – Research Report) today. The company’s shares closed yesterday at $9.05. Leverage the power of TipRanks' Smart ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Kura Oncology (KURA – Research Report) and Steris (STE – Research Report) with bullish sentiments.

If you are looking for ways to make sure even your older Blu-rays perform as well as they can with your new 4K TV, this UBP-X700M model is a 4K Blu-ray player with excellent upscaling even for ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Join us for a special night at KeyBank Center when Rob Ray becomes the 44th member of the Buffalo Sabres Hall of Fame during a pregame ceremony ahead of our game against the Nashville Predators ...

Jane LaCroix is a Newsweek writer based in Miami, FL. Her focus is reporting on U.S. celebrity news and viral trends. She has in depth knowledge of celebrity and internet culture and has covered ...

Visa is the first partner for X Money accounts, which X says will support instant bank transfers and P2P payments. Visa is the first partner for X Money accounts, which X says will support ...

New York | Investor exuberance over artificial intelligence has fuelled a “bubble” in US stocks that resembles the build-up to the dotcom bust at the turn of the millennium, billionaire ...